Staunch critic of Big Pharma IP strategies confirmed as US Health Secretary
Xavier Becerra may push for anti-patentee policies at HHS, but much remains unknown about the Biden administration’s approach
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.